PhRMA Japan raises 10 questions on problems with the health care sector

22 January 2007

Ira Wolf, the representative of the Pharmaceutical Research and Manufacturers of America in Japan, has presented 10 questions about the Japanese health care system in his new year greeting to the country's government.

In the message, he said: "I believe these questions must be answered to solve the daunting challenges that Japan faces with its aging society, to understand how the health care system impacts patient outcomes, and to ensure that patients are properly served by having full access to the fruits of pharmaceutical developments throughout the world."

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK









Company Spotlight